Source - RNS
RNS Number : 5450O
Sinclair Pharma PLC
18 May 2018

Sinclair Pharma plc

Publication of Annual Report and Accounts

London, 18 May 2018 Sinclair Pharma plc (SPH.L), ("Sinclair" or the "Company") the international aesthetics company, announces that its Annual Report and Accounts for the year ended 31 December 2017 is available at the Company's website, and will be posted to shareholders shortly.

For further information please contact:


Sinclair Pharma plc

Tel: +44 (0) 20 7467 6920

Chris Spooner
Alan Olby
Andy Crane

Peel Hunt LLP (NOMAD and Joint Broker)

Tel: +44 (0) 20 7418 8900

James Steel
Oliver Jackson

RBC Capital Markets (Joint Broker)

Tel: +44 (0) 20 7653 4000

Marcus Jackson
Laura White

Media enquiries

FTI Consulting

Tel: +44 (0) 203 727 1000

Ben Atwell
Brett Pollard


Notes to Editors:

About Sinclair Pharma plc 

Sinclair Pharma plc is an international company operating in the fast growth, high gross margin, self-pay global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The Company is planning entry to multiple new geographic markets and line extension launches over the next few years. Sinclair has an established sales and marketing presence in the leading EU markets, Brazil, South Korea and the US, and has a network of international distributors.

This information is provided by RNS
The company news service from the London Stock Exchange